Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents
Article Abstract:
The long-term outcome of treatment with sirolimus-eluting stents, as compared with bare-metal stents is evaluated by analyzing the data obtained from randomized trials. The results have shown that the use of sirolimus-eluting stents have no significant effect on overall long-term survival and survival free of myocardial infarction, as compared with bare-metal stents, but the risk of stent thrombosis is at least as great as that observed with bare-metal stents.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial
Article Abstract:
An attempt is made to assess whether drug-eluting stents are more effective treatment of in-stent restenosis as compared to conventional balloon angioplasty and to examine the relative merits of a sirolimus-eluting stent and a paclitaxel-eluting stent. The findings indicate that a strategy based on sirolimus or paclitaxel-eluting stents is superior to conventional balloon angioplasty for the prevention of recurrent restenosis.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: Meta-analysis of randomized trials
Article Abstract:
An attempt is made to compare outcomes of sirolimus-eluting and paclitaxel-eluting coronary stents on the basis of data generated by randomized head-to-head clinical trials. It is concluded that patients receiving sirolimus-eluting stents had a significantly lower risk of restenosis and target vessel revascularization compared with those receiving paclitaxel-eluting stents.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel
- Abstracts: Harnessing brain signals shows promise for helping patients with paralysis. George Daley, MD, PhD, talks about the clinical promise of stem cell research
- Abstracts: Harnessing brain signals shows promise for helping patients with paralysis. part 2 Growing role for umbilical cord blood
- Abstracts: The incidence of Kaposi sarcoma among injection drug users with AIDS in the United States. Survival after cancer diagnosis in persons with AIDS
- Abstracts: Costimulation blockade with belatacept in renal transplantation. Immunosuppressive drugs for kidney transplantation